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novel reimbursement schemes for other branded products.CONCLUSIONS:Cancer
drug reimbursement models are setting new benchmark for payers to manage
access and control costs. These models have significant implications for other
expensive branded products.
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DATA DISCLOSURE AN ONGOING PROCESS TOWARDS MORE TRANSPARENCY
Al Rabayah AA
King Hussien Cancer Center, Amman , AL, Jordan
OBJECTIVES: 1) Assess the current status of data disclosure in terms of Medicines
Registration and Quality Assurance, Availability of Medicines, Price of Medicine
and Polices and Practices concerning the promotion of medicines in Jordan; 2)
Disclose the currently available data; 3) Identify where there are gaps in
information. METHODS: Using data disclosure survey tool developed by WHO col-
laborating center in pharmaceutical policy under the Medicines Transparency In-
tiative that was implemented in Jordan(2008-2009). RESULTS: The disclosure sur-
vey results showed that only 20% of the key disclosure data around the four key
MeTA components is available and publicly disclosed, while 60% is available but
not publicly disclosed and 20% is not available. Most of the unavailable data was
related to medicines promotion and standard treatment guidelines polices and
practices. Most of polices/laws, regulations, and practices covering medicines reg-
istration, quality assurance and pricing are available, disclosed and enforcing by
law. The data disclosure process highlightined some challenges in the availability
and access to information such as limited access to some data due to requirement
of fees and limited engament of the private sector in disclosing data especially
when it comes to utilizationa nd expenditure data. CONCLUSIONS: 1) To work on
establishing a national committee with authority to monitor adherence to phar-
maceutical promotion codes of ethics; 2) To work with related parties on establish-
ing a national committee to develop evidence based standard treatment guide-
lines; 3) To work with health authorites such as the JFDA to improve accessibility to
important data such as updated medicines prices and registration status; and 4) To
establish a montoring system in collaboration with related stakholders to update
and review the disclosure status in Jordan regularly in order to monitor progress
through classifying data into A, B, and C categories A: available and publicly dis-
closed B: Available C: Not Available.
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OBJECTIVES: Since 2006, data on migration status is collected through representa-
tive survey in Chile (CASEN-survey). In this survey, around 1% reported being in-
ternational immigrants in this survey; however, 0.67% preferred not to report their
migrations status. This study aimed at exploring the living conditions and health
status of migration status missing values (MS-MV) and compare them to self-re-
ported immigrants in this survey. METHODS: Design: Cross-sectional analysis of
population-based CASEN survey-2006 in Chile (268,873 participants). This analysis
focuses on the 0.67% that did not respond the question on migration status (MS-
MV) (n1577) versus self-reported international immigrants (n1877). Six health
outcomes: any disability (dichotomous), any health problem/accident (AHPA), any
hospitalization/surgery (AHS), any chronic condition/cancer (ACCC), and any med-
ical and emergency attentions. Living conditions: Demographic factors (age, sex,
marital status, urban/rural), socioeconomic status (household income per capita,
employment status and educational level), and material standards (overcrowding,
sanitation index, housing quality standards). Weighted crude and adjusted regres-
sion models were conducted in STATA 10.0.RESULTS:The MS-MV has a higher rate
of children, especially with an ethnic background, and people living in rural set-
tings than immigrants. They show a lower SES (income, education and type of
occupation) and poorer material living conditions than immigrants. The MS-MV
show a higher rate of emergency attentions received in the past month, disability,
and AHS than immigrants. Other health events were not different between these
two population groups. CONCLUSIONS: The MS-MV represents a complex group,
affected by socioeconomic deprivation. Some of them may be undocumented im-
migrants, but there is little direct evidence to support this. Regardless of their
migration status, this is a vulnerable group that needs special consideration in
Chile. Equity-centred policy interventions in Chile should focus on improving the
living standards and protecting the health of those were categorised into this
group, particularly the children.
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OBJECTIVES: Accessibility to pharmacy, including geographic accessibility, is an
important goal every government tries to meet. In this study, we analyze the geo-
graphic distribution and accessibility of pharmacies in the municipal territory of
Qom (a province in Iran) for both pedestrians and drivers. METHODS: The percent-
age of households living at specific distances (150, 300, 450, 600 and 750 meters)
from one pharmacy was calculated using geographic information system (GIS)
capabilities. The analysis was performed a second time for 24-hour, 7-day phar-
macies (with 1, 2 and 3 kilometers distance) to evaluate geographic pharmacy
accessibility during holidays, on weekends, and at night. The maximum acceptable
distances for appropriate geographic pharmacy accessibility in normal days and on
holidays (and weekends) were considered 750 meters and 3 kilometers,
respectively. RESULTS: Our analysis indicated that in normal days about 88% of
households living in Qom have acceptable pedestrian accessibility, and almost all
households have acceptable driving accessibility to a pharmacy. In terms of geo-
graphic accessibility to 24-hour, 7-day pharmacies, the results showed that less
than 30% and 95% of households, have acceptable pedestrian and driver accessi-
bility, respectively. CONCLUSIONS: The geographic accessibility of pharmacies at
night and on holidays has to be addressed by provincial health policymakers. keep-
ing a pharmacy opened during holidays and at nights in the areas 24-hour, 7-day
pharmacy accessibility is poor and also offering financial incentives for pharmacies
to be established in low access areas could be considered as a short term solution.
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OBJECTIVES: To examine the relationships between urgent care activity and mor-
tality among patients admitted to hospital on weekends compared to weekdays.
METHODS: A retrospective analysis was performed of all emergency acute care
admissions in England between April 2009 and March 2011 using National Health
Service Hospital Episode Statistics data. Hospital mortality among patients admit-
ted on weekends as compared to weekdays was analysed using the following mea-
sures; (1) overall deaths; (2) deaths within and after three days of admission (3)
deaths among patients with higher risk conditions and lower risk conditions. The
higher risk conditions consisted of 103 Primary Diagnosis codes (ICD-10) which
accounted for 74% of hospital deaths in England; the remaining codes were cat-
egorised as lower risk conditions. RESULTS: There were 10,221,500 emergency hos-
pital admissions during the two-year study period; 23.8% of the patients were
admitted on weekends. A total of 391,938 patients died in hospital. Weekend ad-
mission was associated with significantly higher mortality as compared to week-
day admission (Odds Ratio 1.11, 95% CI 1.10-1.12). Mortality within three days of
admission (early deaths) was also higher for patients admitted on weekends (OR
1.16, 95%CI (1.14-1.17) and this difference persisted for both higher and lower risks
conditions. However, when early deaths were excluded from the analysis, mortal-
ity was not affected by weekend admission. CONCLUSIONS: As mortality after
three days of admission was not affected by weekend admission, it is probable that
the weekend admission effect on mortality is largely due to higher disease severity
at admission on weekends rather than a consequence of shortfalls in quality of
care on weekends as postulated in previous studies.
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OBJECTIVES: The Affordable Medicines Facility – malaria (AMFm) is a financing
mechanism designed to make artemisinin-based combination therapies (ACTs) a
more accessible treatment for malaria(Laspinall 2008). This study assessed the
deployment of ACTm in southern Ghana. METHODS: The study made a census of
functional pharmacies, licensed chemical shops and private health facilities in the
southern part of Ghana. Structured questionnaires were used to interview atten-
dants at the facilities on knowledge, availability; cost, patronage of the ACTm and
training about the program. RESULTS: Overall, 78% of the facilities stocked the
ACTm. Dome had 86.5% and Taifa, 71.1%. The cost per treatment of ACTm ranged
between GHC 1.00-6.00(0.66-3.96USD). Whilst 59.2% sold ACTm within the recom-
mended range (GHC 1.00-1.50), 40.8% sold it between GHC 2.00-6.00(1.32-3.96USD).
At Dome, cost range was GHC 1.00-6.00 with GHC 2.45(1.62USD), and 2.00(1.32USD)
as the mean and median prices. Taifa, had range GHC 1.00-4.00, with GHC 1.50 as
mean and GHC 1.70(1.12USD) as the median prices. While at Taifa 78.1% of ACTm
stocked facilities sold it between GHC 1.00-1.50, only 40.6% did so at Dome (p-value
less than 0.001). Seventy seven percent of respondents had good knowledge of the
program. The main channels of communication were audio and visual. Thirty
seven percent of respondents were trained about the program. Whilst 96.3% of the
trained stocked ACTm, 67.5% of untrained stocked the drugs (p-value  0.001).
Majority (93.3 %) of the trained preferred ACTm first choice antimalarial, to non-
ACTm, compared to 50% of untrained (p-value  0.001). Overall, 62.2% of respon-
dents reported good patronage. CONCLUSIONS: The results underscore initial ob-
servation that knowledge and availability of ACTm was poor. The ACTm though
well deployed in the southern Ghana, it is more financially accessible in Taifa than
the Dome sub-district hence, difference in patronage.
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POTENTIAL EFFECTS OF CHANGES IN PRICING REGULATIONS BETWEEN 2004
AND 2011 ON THE TURKISH PHARMACEUTICAL INDUSTRY
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Cetinelli ST2
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OBJECTIVES: Estimate the effect of changes in government pricing and reimburse-
ment regulations on the Turkish pharmaceutical industry. Five different product
groups within the pharmaceutical industry between 2004 and 2011 were studied.
METHODS: Five product groups were examined: original products without gener-
ics, original products with generics, generics, 20-year-old generics, and 20-year-old
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originals (any pharmaceutical released before 01/08/1987, per 2007 decree). The
product reference price was assumed to be 100 for all groups. The effect of
amended regulations was estimated for all five product groups by applying the
changed discount rates to the reference price throughout the years 2004 to 2011.
RESULTS: The reference price in 2004 was considerably different than in 2012. The
price of original products without generics decreased from 100 to 59. The price of
generics, and original products with generics decreased to 47.5. The 20-year-old
original and generic products were affected the least, as the price of the 20-year-old
original products decreased to 69.1 and of generics to 71.3. The different effects of
regulations on each product group indicate that companies are heterogeneously
affected depending on inventory. CONCLUSIONS: Drug groups were not uniformly
affected by the regulations. With less overhead and expenses (e.g., clinical trials,
marketing, promotions), generic drug manufactures are more easily adaptable to
new regulations and market conditions. This may cause a shift to extensive pro-
duction of generic medications in the Turkish pharmaceutical industry and de-
crease research and development investments.
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OBJECTIVES: To evaluate Public Perception towards Medicine Quality and Prices in
Afghanistan. METHODS: A cross-sectional descriptive survey involving 1282 pop-
ulation in six zones of Afghanistan was undertaken. RESULTS: The study findings
revealed that a total of (50.2%) of respondents agreed that imported medicines and
(41.4%) said that locally manufactured medicines have good quality. High propor-
tions (61.4%) of Afghan doctors are prescribing quality medicines, and also medi-
cines given by public hospitals in Afghanistan are of high quality (54.9%). (38.4%)
agreed that the afghan drug regulatory authority controls quality of medicine.
Interestingly, (96.3%) respondents were agreed, that Afghan government should
adopt health policies to control the medicine prices and expenditure. (89.6%) re-
spondents agree that higher medicine costs negatively impacts patient outcomes.
Half of the respondents (44.5%) say that in Afghanistan doctors have poor under-
standings on medicine prices. (68.7%) of respondents agreed that the price regula-
tion system should be implemented from manufacturer to patients. When respon-
dents asked, (94%) agreed that all medicine need to be disclosed on the dispensed
medicine label. A round, (19.9%) of respondents agreed that medicine prices in
Afghanistan are affordable to everyone. (93.1%) of the respondents said, prescrip-
tion drug prices need to be regulated by the government. When respondents asked
(68.2%) agreed that medicine prices are high in private hospitals. CONCLUSIONS:
The first national survey on medicine quality and pricing, suggests that, the gov-
ernment should take firm steps to control the quality and disparate medicine
prices, to ensure accessibility, availability and affordability of medicine to all. The
drug regulatory authority has less control to regulate medicine quality and prices,
due to critical factors, e.g. lack of qualified staff and quality control lab, insufficient
salaries and corruption. No medicine pricing policy is in place and pro-poor med-
icine pricing policy development is crucial.
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OBJECTIVES: To delineate family physicians’ and rheumatologists’ point of view
when primary care is facing cases of rheumatic diseases. To experimentally iden-
tify barriers in the reference and counter reference.METHODS:This is a pilot study,
transversally designed, with family physicians and rheumatologists in a single city.
Methodological steps: 1) Development and preparation of three clinical scenarios
that simulate and address different levels of clinical severity; 2) application of these
scenarios in the sample; 3) validation of the study scenarios. Final scenarios: a)
Scenario one: patient with an autoimmune disease diagnosis presenting fever and
fatigue; b) Scenario two: patient with fibromyalgia and with poor adherence to the
health care plan, requiring a medication to relief the symptoms; c) Scenario three:
patient with septic arthritis, prostration, and in poor clinical conditions. Decisions
to be chosen: Decision 1: To apply a health care plan (investigation and/ or treat-
ment) and refer to a rheumatologist; Decision 2: to prescribe medication and do not
reference to rheumatologist; Decision 3: to refer to a rheumatologist with no pri-
mary care intervention. Afterwards, a multiple-choice questionnaire addressing
potential factors that lead to barriers in the reference and counter reference pro-
cess was applied. Descriptive analysis was performed to map the results and boot-
strap method for constructing hypothesis tests. RESULTS: Twenty-two family phy-
sicians and rheumatologists were involved. For Scenario one, the majority of
interviewee chose Decision 1 [1.27 (1 –3), SD 0.59)]. For the Scenario two, respondents
chose the decision 2 [2 (1 – 3), SD 0.76)]. For the Scenario three, decision three was the
preferred [1.47 (1 –3), SD 0.83)]. For the reference and counter-reference evaluation,
interviewee considered that there is a poor communication between family phy-
sician and rheumatologist [4.2 (2 – 5), SD 1.01)]. CONCLUSIONS: Proper communi-
cation seems to be a hurdle for the reference and counter reference system.
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OBJECTIVES: The objective of this analysis is to examine socioeconomic inequali-
ties in health. It investigates whether, and to what extent, household economic
status and other socio-demographic variables are associated with the health of
individuals residing in urban areas of Pakistan. METHODS: The study uses data
from the Pakistan Socioeconomic Survey (PSES) and analysis is based on 11,069
individuals who belong to 1,435 urban households. Health status is based on self-
reported morbidity during the two weeks preceding the interview. Household eco-
nomic status is measured by a wealth index constructed using data from the sur-
vey on ownership of durable assets and housing conditions. Principal components
analysis (PCA) is used to construct the index and households are categorised into
quintiles by PCA scores. The logistic regression is used to estimate the effects of
various social, demographic, economic and regional characteristics of individuals/
households on health status. RESULTS: Overall, 12.7% individuals reported any
health complaint during the two weeks preceding the interview. Male household
members have lower prevalence of morbidity (10.6%) compared to females (14.9%).
A total of 17.6% members of the lowest quintile reported any health complaint
compared to 11% of the highest quintile. Furthermore, highest morbidity was re-
ported by members of Muslim households (12.9%), widowed/divorced/separated
members (26.2%), those with no education (16.8%), agriculture/fisheries workers
(18.3%) and those residing in urban areas of Balochistan (14.2%). The logistic regres-
sion exhibits a strong significant (p0.01) association between household eco-
nomic status and health status. Members of poorest, poor, middle and rich house-
holds are significantly (p0.01) more likely to report any health complaint
compared to members of the richest households, controlling for gender and age,
religion, marital status, education, occupation, and residence in an area.
CONCLUSIONS: Socioeconomic inequalities in health are widespread in urban Pak-
istan. Public health policies aimed at reducing gaps between health status of poor
and non-poor need to be initiated.
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OBJECTIVES: A review of the entire currently listed drugs that had been eligible for
subsidy was carried out by the Health Insurance Review and Assessment Service
(HIRA) in South Korea. As a result of this review, the government can decide
whether a drug should no longer be on the reimbursement drugs list. This study
described how these reviews were carried out and the currently listed drugs were
changed. METHODS: The currently listed drugs were divided into a total 49 thera-
peutic groups. The cost-effectiveness analyses were conducted to review of the
first therapeutic groups (pilot review, migraine and hyperlipidemia drugs). How-
ever, in the others therapeutic groups their clinical usefulness and price reason-
ableness were reviewed respectively without the cost-effectiveness analysis, be-
cause the review framework was changed to improve the efficiency of review by
the government. Accordingly, the drugs were delisted when the evidence of clinical
usefulness were not founded and drugs’ prices were the higher than 80 percentile
of the highest price among drugs containing the same ingredients. RESULTS: As
the result of pilot review, 371 drugs (98.1%) were decided to be on the reimburse-
ment drugs list and 7 drugs (1.9%) were delisted. For drugs maintained on the list,
128 drugs (34.5%) had price cut. After the review framework is changed, 557 drugs
(4.1%) were delisted and 3,705 drugs (28.7%) had price cut. For drugs delisted, 446
drugs (80.1%) had no clinical usefulness and 111 drugs (19.9%) were delisted be-
cause of several reasons such as fact that pharmaceutical companies did not ac-
cept to reduce drug prices. As a result, Of the total 13,844 drugs, 564 drugs (4.1%)
were delisted and for drugs remained on the list, 3,831 drugs (28.8%) had price cut.
CONCLUSIONS: This study could be helpful for understanding the currently listed
drugs review. In the future, monitoring for the currently listed drugs utilization
pattern should be needed.
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THE EFFECT OF RESETTING THE CLOCK IN HEALTH CARE
Gresz M1, Varga S2, Sebestyén A3, Toldi J2, Bogár L2, Molics B2, Boncz I2
1National Institute for Quality- and Organizational Development in Healthcare and Medicines,
Budapest, Hungary, 2University of Pécs, Pécs, Hungary, 3South-Trasdanubian Regional Health
Insurance Fund Administration, Pécs, Hungary
OBJECTIVES: The resetting the clock was introduced at the beginning of the last
century in Hungary. Since then it has been maintained almost continually. Energy-
saving has been the aim of the resetting the clock. The question is what the effect
of the spring and fall time-shift for the human body is, how the human body can
tolerate the effect of the spring and fall resetting the clock. METHODS: The data of
the National Health Insurance Fund Administration were summarized from 1999
to 2011. That included 83 million out-patient and 2.7 million inpatient cases. The
BNO main diagnoses of the week before resetting the clock were compared to the
main diagnoses of the week after resetting the clock. RESULTS: The number of the
out-patient cases decreased after resetting the clock. The number of the in-patient
cases increased after both, the spring end the autumn resetting the clock. The
highest increased was showed in the psychiatric patients. After resetting the clock,
on Monday, the number of the hospitalized patients doubled. The psychiatric di-
agnoses, using the BNO code system, were 3.8-fold, the diseases, related to circu-
latory system was 1.9-fold and the traumatological cases were 1.5-fold after reset-
ting the clock. CONCLUSIONS: The economical benefit of resetting the clock can be
questioned in the view of the plus 53,000 hospitalized patients (14,000 more circu-
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